Adding hormonal therapy to chemotherapy and trastuzumab improves prognosis in patients with hormone receptor-positive and human epidermal growth factor receptor 2-positive primary breast cancer

By Hayashi Naoki  

Breast Cancer Research and Treatment, Vol. 137, Iss. 2, 2013-01 ,pp. : 523-531

Springer Publishing Company

Access to resources Recommend Favorite

Serum folliclestimulating hormone level is associated with human epidermal growth factor receptor type 2 and Ki67 expression in postmenopausal females with breast cancer

By            

Oncology Letters, Vol. 6, Iss. 4, 2013-01 ,pp. : 1128-1132

Spandidos Publications

Access to resources Recommend Favorite

Human epidermal growth factor receptor 2 protein expression between primary breast cancer and paired asynchronous local-regional recurrences

By                

Experimental and Therapeutic Medicine, Vol. 2, Iss. 6, 2011-01 ,pp. : 1187-1191

Spandidos Publications

Access to resources Recommend Favorite

Reproducibility of human epidermal growth factor receptor 2 analysis in primary breast cancer - A national survey performed at pathology departments in Sweden

By Ryden Lisa   Haglund Monica   Bendahl Par-Ola   Hatschek Thomas   Kolaric Aleksandra   Kovacs Aniko   Olsson Ann   Olsson Hans   Strand Carina   Ferno Mårten  

Acta Oncologica, Vol. 48, Iss. 6, 2009-08 ,pp. : 860-866

Informa Healthcare

Access to resources Recommend Favorite

Association of human epidermal growth factor receptor 2 status with ipsilateral breast tumor recurrence and resistance to endocrine therapy

By          

Molecular and Clinical Oncology, Vol. 3, Iss. 4, 2015-01 ,pp. : 843-846

Science Publishers

Access to resources Recommend Favorite